Portfolio Strategy & Bd, Consultant
London, Gb
Collaborate with pharmaceutical and biotech companies across discovery, preclinical, clinical, and business development sectors, providing information, data, and guidance specific to each client's needs. Experience spans life sciences services, including: - competitive intelligence reports- business development & licensing intelligence reports- drug portfolio optimization- asset identification and re-positioning- disease and drug market analyses (primary + secondary research)- molecular and chemical target identification- bioinformatic gene pathway analysisConduct primary market research to assess unmet need and market acceptance for new drug concepts. Recruited and interviewed >100 KOLs (physicians, scientists, and investors) on topics, such as rare diseases, immuno-oncology, cell therapy, academic deal structure, and intellectual property.Clarivate database expertise includes: Cortellis (Competitive, Clinical, Regulatory, and Deal Intelligence), Newport (generics and APIs), Integrity (pre-clinical), Innovation (Derwent World Patents Index data), MetaCore (gene pathway analysis), and Web of Science (literature and publication indicators).https://clarivate.com/products/life-sciences-professional-services/portfolio-licensing/